Stockscreener 앱 받기
0.00
100.00%
-1.16
시간 외 거래:
1.15
1.15
+
전일 마감가:
$1.16
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$N/A
수익:
$14.86M
순이익/손실:
$-56.00M
주가수익비율:
0.00
EPS:
-4.5442
순현금흐름:
$-45.58M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$1.18
Hookipa Pharma Inc Stock (HOOK) Company Profile
Compare HOOK vs VRTX, REGN, MRNA, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOOK
Hookipa Pharma Inc
|
0.00 | 0 | 14.86M | -56.00M | -45.58M | -4.5442 |
VRTX
Vertex Pharmaceuticals Inc
|
510.72 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
798.17 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
172.94 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
988.20 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
365.67 | 39.20B | 5.76B | 514.49M | 1.10B | 4.4813 |
Hookipa Pharma Inc Stock (HOOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-20 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-11-15 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-12-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2021-11-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-08 | 개시 | Morgan Stanley | Overweight |
| 2020-11-03 | 개시 | Truist | Buy |
| 2020-10-26 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-19 | 재개 | H.C. Wainwright | Buy |
| 2019-09-27 | 개시 | H.C. Wainwright | Buy |
| 2019-05-13 | 개시 | BofA/Merrill | Buy |
| 2019-05-13 | 개시 | RBC Capital Mkts | Outperform |
모두보기
Hookipa Pharma Inc 주식(HOOK)의 최신 뉴스
HOOK stock trades quietly as HOOKIPA Pharma focuses on vaccine pipeline - ad-hoc-news.de
HOOKIPA Pharma Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com
HOOKIPA Pharma Inc Market Sentiment - Benzinga España
HOOKIPA Pharma (HOOK) AGM 2024 Summary - Quartr
Hookipa Pharma Inc (HOOK) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Hookipa Pharma focuses on clinical-stage immunotherapies as investor interest in biotech stays eleva - Ad-hoc-news.de
HOOKIPA Pharma Inc (HOOK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
HOOKIPA Pharma Inc (HOOK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
HOOKIPA Pharma Inc (HOOK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
HOOKIPA Pharma Inc (HOOK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
HOOKIPA Pharma Inc (HOOK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Institutional Confidence - TradingKey
HOOKIPA Pharma Inc (HOOK) Valuation: PE, PB & Fair Value Analysis - TradingKey
HOOKIPA Pharma Inc (HOOK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
HOOKIPA Pharma Inc (HOOK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Immuno-oncology small cap after recent funding and pipeline - AD HOC NEWS
Stock Quote - StocksToTrade
HOOKIPA Pharma stock (US43906K1007): cash runway update and pipeline focus after latest quarterly re - AD HOC NEWS
HOOKIPA Pharma stock (US43906K1007): pipeline update keeps immunotherapy story in focus - AD HOC NEWS
HOOKIPA Pharma Inc.Common Stock (Nasdaq:HOOK) Stock Quote - The Chronicle-Journal
HOOKIPA Pharma Inc stock (US43906K1007): Delisted to OTC amid price volatility - AD HOC NEWS
TradingKey - TradingKey
HOOKIPA Pharma Inc stock (US43906K1007): Biotech focuses on infectious disease and oncology pipeline - AD HOC NEWS
HOOKIPA Pharma Inc stock (US43906K1007): Is its viral vector platform strong enough to unlock biotec - AD HOC NEWS
Can HOOKIPA Pharma Inc reach all time highs this yearQuarterly Portfolio Review & Safe Swing Trade Setup Alerts - baoquankhu1.vn
Earnings Report: Can HOOKIPA Pharma Inc reach all time highs this year - baoquankhu1.vn
New Highs: How does HOOKIPA Pharma Inc compare to its peersQuarterly Risk Review & Community Trade Idea Sharing Platform - baoquankhu1.vn
Winners Losers: Is HOOKIPA Pharma Inc stock a smart retirement pick2026 Support & Resistance & Safe Capital Allocation Plans - baoquankhu1.vn
HOOKIPA Pharma Inc Stock: Areola Virus Vaccine Innovator Seeks Prophylactic Breakthrough with ISIN U - AD HOC NEWS
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics - markets.businessinsider.com
NeoTrail Therapeutics, Inc. completed the acquisition of Oncology Assets from HOOKIPA Pharma Inc. (OTCPK : HOOK). - MarketScreener
Breakout Move: How does HOOKIPA Pharma Inc compare to its peers2026 Sector Review & Real-Time Volume Triggers - baoquankhu1.vn
HOOKIPA Pharma Inc stock faces renewed scrutiny after failed merger and pipeline updates in biotech - AD HOC NEWS
Gilead (GILD) to Acquire HOOK for $10 million - msn.com
HOOKIPA Pharma Stock: What Latest Pipeline Moves Mean for U.S. Investors - AD HOC NEWS
HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - Yahoo Finance
HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewswire
HOOKIPA Pharma to delist from Nasdaq and liquidate following Gilead asset sale - MSN
HOOK Stock Price and Chart — OTC:HOOK - TradingView
HOOK Stock Price, Quote & Chart | HOOKIPA PHARMA INC (NASDAQ:HOOK) - ChartMill
[S-8 POS] HOOKIPA Pharma Inc. SEC Filing - Stock Titan
Hookipa, having sold off vaccines to Gilead, opts to wind down - Fierce Biotech
Hookipa Pharma to Delist from Nasdaq Amid Asset Sale - The Globe and Mail
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - Yahoo Finance
HOOKIPA Pharma(Delisted) (HOOK) Revenue BreakdownMain Composition - Moomoo
Gilead pays partner Hookipa $10M to take over HBV, HIV therapeutic vaccine programs - Fierce Biotech
HOOK Stock Price, News & Analysis - Stock Titan
Hookipa Pharma stock plunges to 52-week low of $1.11 amid steep decline - Investing.com India
Hookipa Pharma stock hits 52-week low at $1.34 amid sharp decline - Investing.com
Poolbeg slumps as Hookipa merger is called off - pharmaphorum
HOOKIPA Pharma Inc. Announces Decision Against All-Share Acquisition of Poolbeg Pharma plc | HOOK Stock News - Quiver Quantitative
Hookipa Pharma Inc (HOOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
1.96%
자본화:
|
볼륨(24시간):